Literature DB >> 23793925

Decreased expression and aberrant methylation of Gadd45G is associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma.

Wei Guo1, Tienian Zhu, Zhiming Dong, Lei Cui, Minghui Zhang, Gang Kuang.   

Abstract

The growth arrest DNA damage-inducible gene (Gadd45) family, which is composed of Gadd45A, Gadd45B, and Gadd45G, is involved in DNA damage response and cell growth arrest. The present study was to detect the role of Gadd45 gene family in esophageal cancer and the relationship of Gadd45G methylation to a series of pathological parameters in a large esophageal squamous cell carcinoma (ESCC) sample, in order to elucidate more information on the role of Gadd45 gene family with regard to the pathogenesis of ESCC. Frequent silencing of Gadd45G but not Gadd45A and Gadd45B were found in esophageal cancer cell lines and the silencing of Gadd45G may be reversed by 5-Aza-dC or TSA treatment in Eca109 cell line. The aberrant proximal promoter methylation of Gadd45G induces silencing of Gadd45G expression in Eca109 cell line. Gadd45A mRNA and protein expression in ESCC tumor tissues was significantly different compared to corresponding normal tissues. Decreased mRNA and protein expression of Gadd45G was observed in ESCC tumor tissues and was associated with Gadd45G proximal promoter methylation. Gadd45A or Gadd45B expression was not correlated with ESCC patients survival, while Gadd45G methylation status and protein expression were independently associated with ESCC patients' survival. These data indicated that Gadd45G may be a functional tumor suppressor and its inactivation through proximal promoter methylation may play an important role in ESCC carcinogenesis and reactivation of Gadd45G gene may has therapeutic potential and may be used as a prognostic marker for ESCC patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23793925     DOI: 10.1007/s10585-013-9597-2

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  45 in total

1.  Genes, genetics, and epigenetics: a correspondence.

Authors:  J R Morris
Journal:  Science       Date:  2001-08-10       Impact factor: 47.728

Review 2.  Chromatin immunoprecipitation assay.

Authors:  Partha M Das; Kavitha Ramachandran; Jane vanWert; Rakesh Singal
Journal:  Biotechniques       Date:  2004-12       Impact factor: 1.993

3.  Down-regulation of Gadd45 expression is associated with tumor differentiation in non-small cell lung cancer.

Authors:  Hiroshi Higashi; Daniel Vallböhmer; Ute Warnecke-Eberz; Shuichi Hokita; Huan Xi; Jan Brabender; Ralf Metzger; Stephan E Baldus; Shoji Natsugoe; Takashi Aikou; Arnulf H Hölscher; Paul M Schneider
Journal:  Anticancer Res       Date:  2006 May-Jun       Impact factor: 2.480

Review 4.  Gadd45 proteins as critical signal transducers linking NF-kappaB to MAPK cascades.

Authors:  Z Yang; L Song; C Huang
Journal:  Curr Cancer Drug Targets       Date:  2009-12       Impact factor: 3.428

5.  Analysis of methylation-sensitive transcriptome identifies GADD45a as a frequently methylated gene in breast cancer.

Authors:  Wei Wang; Gudrun Huper; Yueqi Guo; Susan K Murphy; John A Olson; Jeffrey R Marks
Journal:  Oncogene       Date:  2005-04-14       Impact factor: 9.867

6.  Hypermethylation of growth arrest DNA-damage-inducible gene 45 in non-small cell lung cancer and its relationship with clinicopathologic features.

Authors:  Yeon Kyung Na; Su Man Lee; Hae Sook Hong; Jae Bum Kim; Jae Yong Park; Dong Sun Kim
Journal:  Mol Cells       Date:  2010-07-14       Impact factor: 5.034

7.  MethPrimer: designing primers for methylation PCRs.

Authors:  Long-Cheng Li; Rajvir Dahiya
Journal:  Bioinformatics       Date:  2002-11       Impact factor: 6.937

Review 8.  Growth arrest and DNA damage-45 alpha (GADD45alpha).

Authors:  A Rosemary Siafakas; Des R Richardson
Journal:  Int J Biochem Cell Biol       Date:  2008-08-05       Impact factor: 5.085

9.  Novel glioblastoma markers with diagnostic and prognostic value identified through transcriptome analysis.

Authors:  Sreekanth P Reddy; Ramona Britto; Katyayni Vinnakota; Hebbar Aparna; Hari Kishore Sreepathi; Balaram Thota; Arpana Kumari; B M Shilpa; M Vrinda; Srikantha Umesh; Cini Samuel; Mitesh Shetty; Ashwani Tandon; Paritosh Pandey; Sridevi Hegde; A S Hegde; Anandh Balasubramaniam; B A Chandramouli; Vani Santosh; Paturu Kondaiah; Kumaravel Somasundaram; M R Satyanarayana Rao
Journal:  Clin Cancer Res       Date:  2008-05-15       Impact factor: 12.531

10.  Methylation-mediated repression of GADD45alpha in prostate cancer and its role as a potential therapeutic target.

Authors:  Kavitha Ramachandran; Gopal Gopisetty; Edna Gordian; Loida Navarro; Christiane Hader; Isildinha M Reis; Wolfgang A Schulz; Rakesh Singal
Journal:  Cancer Res       Date:  2009-02-03       Impact factor: 12.701

View more
  15 in total

1.  Network-based analysis identifies epigenetic biomarkers of esophageal squamous cell carcinoma progression.

Authors:  Chun-Pei Cheng; I-Ying Kuo; Hakan Alakus; Kelly A Frazer; Olivier Harismendy; Yi-Ching Wang; Vincent S Tseng
Journal:  Bioinformatics       Date:  2014-07-10       Impact factor: 6.937

2.  GADD45G Interacts with E-cadherin to Suppress the Migration and Invasion of Esophageal Squamous Cell Carcinoma.

Authors:  Tongtong Li; Lele Xu; Jinglei Teng; Yunping Ma; Wenzhong Liu; Yan Wang; Xinming Chi; Shujuan Shao; Yan Dong; Qimin Zhan; Xuefeng Liu
Journal:  Dig Dis Sci       Date:  2019-09-27       Impact factor: 3.199

3.  GADD45 in Stress Signaling, Cell Cycle Control, and Apoptosis.

Authors:  Arslon Humayun; Albert J Fornace
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 4.  Roles for GADD45 in Development and Cancer.

Authors:  Kishan Patel; Mary Grace Murray; Kelly A Whelan
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

5.  Epigenomic characterization of locally advanced anal cancer: a radiation therapy oncology group 98-11 specimen study.

Authors:  Erin M Siegel; Steven Eschrich; Kathryn Winter; Bridget Riggs; Anders Berglund; Abidemi Ajidahun; Jeff Simko; Jennifer Moughan; Jaffer Ajani; Anthony Magliocco; Abul Elahi; Sarah Hoffe; David Shibata
Journal:  Dis Colon Rectum       Date:  2014-08       Impact factor: 4.585

Review 6.  Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma.

Authors:  Yunli Zhou; Xun Zhang; Anne Klibanski
Journal:  Mol Cell Endocrinol       Date:  2013-09-11       Impact factor: 4.102

7.  Integration of multiple networks and pathways identifies cancer driver genes in pan-cancer analysis.

Authors:  Claudia Cava; Gloria Bertoli; Antonio Colaprico; Catharina Olsen; Gianluca Bontempi; Isabella Castiglioni
Journal:  BMC Genomics       Date:  2018-01-06       Impact factor: 3.969

8.  GSK-J4-Mediated Transcriptomic Alterations in Differentiating Embryoid Bodies.

Authors:  Chanchal Mandal; Sun Hwa Kim; Sung Chul Kang; Jin Choul Chai; Young Seek Lee; Kyoung Hwa Jung; Young Gyu Chai
Journal:  Mol Cells       Date:  2017-10-17       Impact factor: 5.034

9.  Activating transcription factor 4 promotes esophageal squamous cell carcinoma invasion and metastasis in mice and is associated with poor prognosis in human patients.

Authors:  Hongwu Zhu; Xiong Chen; Bin Chen; Bei Chen; Weibing Song; Dayong Sun; Yagang Zhao
Journal:  PLoS One       Date:  2014-07-31       Impact factor: 3.240

10.  A 35-gene signature discriminates between rapidly- and slowly-progressing glioblastoma multiforme and predicts survival in known subtypes of the cancer.

Authors:  Azeez A Fatai; Junaid Gamieldien
Journal:  BMC Cancer       Date:  2018-04-03       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.